← Leaderboards

Mel B Feany

Brigham And Women'S Hospital

Google Scholar ↗PubMed ↗ORCID ↗

$26,965,920

Attributed

$33,160,217

Total exposure

22

Grants

19

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.3M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$33,160,217 · 22

By mechanism

R01$12,269,987 · 7

RF1$11,799,640 · 3

R21$3,232,233 · 7

R35$2,737,431 · 1

P01$1,926,638 · 2

P50$771,792 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Richard L Stevens$8,274,576
Lee E Goldstein$17,632,006

Others in their field

Top investigators on “Alzheimer&Apos”

Jose A Luchsinger · Columbia University Health Sciences$56,595,040
Eric M Reiman · Banner Health$48,982,487
Yadong Huang · J. David Gladstone Institutes$40,311,515
Lindsay A. Farrer · Boston University Medical Campus$34,189,802
David M Holtzman · Washington University$28,985,806
Michael W Weiner · Northern California Institute Res &Educ$28,197,224

Research focus

Alzheimer&AposDrosophila GenusNeuronsNerve DegenerationNeurodegenerative DisordersGeneticGenesToxic EffectNeurotoxicityS DiseaseGenetic ScreeningPathway InteractionsCellsBiological ModelsMediatingTau ProteinsProteinsDepositionPathogenesisMutationCessation Of LifeBiochemicalBaseMolecular

Grant awards (68)

Functional analysis of glia in tauopathy$1,613,138

RF1 · FY2025 · AG · contact PI

Genetic Analysis of Neurodegeneration$921,694

R35 · FY2025 · NS · contact PI

Genetic Analysis of Neurodegeneration$894,043

R35 · FY2024 · NS · contact PI

Anastasis in age-related neurodegeneration$223,750

R21 · FY2024 · AG · contact PI

Genetic Analysis of Neurodegeneration$921,694

R35 · FY2023 · NS · contact PI

Anastasis in age-related neurodegeneration$268,500

R21 · FY2023 · AG · contact PI

Functional analysis of glia in tauopathy$2,531,613

RF1 · FY2022 · AG · contact PI

Genome Wide Analysis of Alpha-Synuclein Neurotoxicity$585,729

R01 · FY2021 · NS · contact PI

Genome Wide Analysis of Alpha-Synuclein Neurotoxicity$585,729

R01 · FY2020 · NS · contact PI

Genome Wide Analysis of Alpha-Synuclein Neurotoxicity$585,729

R01 · FY2019 · NS · contact PI

Functional analysis of glia in tauopathy$223,750

R21 · FY2019 · AG · contact PI

Functional analysis of glia in alpha-synucleinopathy$223,750

R21 · FY2019 · NS · contact PI

Genome Wide Analysis of Alpha-Synuclein Neurotoxicity$179,000

R01 · FY2019 · NS · contact PI

Genome Wide Analysis of Alpha-Synuclein Neurotoxicity$585,729

R01 · FY2018 · NS · contact PI

Functional analysis of glia in tauopathy$268,500

R21 · FY2018 · AG · contact PI

Functional analysis of glia in alpha-synucleinopathy$268,500

R21 · FY2018 · NS · contact PI

Integrative Multi-Omic Discovery of Proximal Mechanisms Driving Age-Dependent Neurodegeneration$4,760,794

RF1 · FY2017 · AG · contact PI

Peripheral Control of Brain Proteostasis in Aging and Alzheimer Disease$2,894,095

RF1 · FY2017 · AG · contact PI

Genome Wide Analysis of Alpha-Synuclein Neurotoxicity$610,729

R01 · FY2017 · NS · contact PI

Genome-wide analysis of tau neurotoxicity$408,113

R01 · FY2016 · AG · contact PI

Biochemical and in vivo determinants of tau neurotoxicity$459,914

R01 · FY2015 · NS · contact PI

Genome-wide analysis of tau neurotoxicity$395,776

R01 · FY2015 · AG · contact PI

Drosophila Model of Alexander Disease$380,184

P01 · FY2015 · HD · contact PI

Biochemical and in vivo determinants of tau neurotoxicity$455,314

R01 · FY2014 · NS · contact PI

Genome-wide analysis of tau neurotoxicity$406,868

R01 · FY2014 · AG · contact PI

Drosophila Model of Alexander Disease$358,559

P01 · FY2014 · HD · contact PI

Reductive Stress in Complex I Deficiency$218,882

R21 · FY2014 · NS · contact PI

Biochemical and in vivo determinants of tau neurotoxicity$472,747

R01 · FY2013 · NS · contact PI

Genome-wide analysis of tau neurotoxicity$383,405

R01 · FY2013 · AG · contact PI

Reductive Stress in Complex I Deficiency$264,563

R21 · FY2013 · NS · contact PI

Biochemical and in vivo determinants of tau neurotoxicity$508,142

R01 · FY2012 · NS · contact PI

Genome-wide analysis of tau neurotoxicity$405,144

R01 · FY2012 · AG · contact PI

Pharmacological modulation of tau neurotoxicity in vivo$227,588

R21 · FY2012 · AG · contact PI

Mechanisms Underlying Neuronal Cell Type Specificity in Neurodegeneration$273,105

R01 · FY2011 · AG · contact PI

Pharmacological modulation of tau neurotoxicity in vivo$189,612

R21 · FY2011 · AG · contact PI

Mechanisms Underlying Neuronal Cell Type Specificity in Neurodegeneration$284,130

R01 · FY2010 · AG · contact PI

Chemical modulation of lysosomal storage in vivo$244,750

R21 · FY2010 · NS · contact PI

Drosophila Models of Alexander Disease$588,045

P01 · FY2009 · NS · contact PI

Mechanisms Underlying Neuronal Cell Type Specificity in Neurodegeneration$287,000

R01 · FY2009 · AG · contact PI

Chemical modulation of lysosomal storage in vivo$243,604

R21 · FY2009 · NS · contact PI

Drosophila Models of Alexander Disease$599,850

P01 · FY2008 · NS · contact PI

Mechanisms Underlying Neuronal Cell Type Specificity in Neurodegeneration$287,000

R01 · FY2008 · AG · contact PI

PHOSPHORYLATION CONTROL OF TAU NEUROTOXICITY IN DROSOPHILA$181,975

P50 · FY2008 · AG · contact PI

Drosophila model of amyotrophic lateral sclerosis$265,533

R01 · FY2007 · NS · contact PI

PHOSPHORYLATION CONTROL OF TAU NEUROTOXICITY IN DROSOPHILA$185,207

P50 · FY2007 · AG · contact PI

Aging in Drosophila models of human neurodegeneration$180,546

R21 · FY2007 · AG · contact PI

Drosophila model of amyotrophic lateral sclerosis$273,463

R01 · FY2006 · NS · contact PI

Aging in Drosophila models of human neurodegeneration$185,938

R21 · FY2006 · AG · contact PI

PHOSPHORYLATION CONTROL--TAU NEUROTOXICITY IN DROSOPHILA$132,611

P50 · FY2006 · AG · contact PI

Drosophila Model of Parkinson's Disease$296,625

R01 · FY2005 · NS

Genetic Dissection of Neurodegenerative Dementias$284,760

R01 · FY2005 · AG

Drosophila model of amyotrophic lateral sclerosis$280,044

R01 · FY2005 · NS

PHOSPHORYLATION CONTROL--TAU NEUROTOXICITY IN DROSOPHILA$128,750

P50 · FY2005 · AG

Drosophila Model of Parkinson's Disease$32,550

R01 · FY2005 · NS

Drosophila model of amyotrophic lateral sclerosis$303,169

R01 · FY2004 · NS

Drosophila Model of Parkinson's Disease$296,625

R01 · FY2004 · NS

Genetic Dissection of Neurodegenerative Dementias$284,760

R01 · FY2004 · AG

PHOSPHORYLATION CONTROL--TAU NEUROTOXICITY IN DROSOPHILA$143,249

P50 · FY2004 · AG

Drosophila Model of Parkinson's Disease$296,625

R01 · FY2003 · NS

Genetic Dissection of Neurodegenerative Dementias$284,760

R01 · FY2003 · AG

GENETIC MODEL OF NEURODEGENERATION$103,140

K08 · FY2003 · AG

Drosophila Model of Parkinson's Disease$296,625

R01 · FY2002 · NS

Genetic Dissection of Neurodegenerative Dementias$284,760

R01 · FY2002 · AG

GENETIC MODEL OF NEURODEGENERATION$103,140

K08 · FY2002 · AG

Drosophila Model of Parkinson's Disease$321,625

R01 · FY2001 · NS

Genetic Dissection of Neurodegenerative Dementias$308,760

R01 · FY2001 · AG

GENETIC MODEL OF NEURODEGENERATION$116,208

K08 · FY2001 · AG

GENETIC MODEL OF NEURODEGENERATION$100,008

K08 · FY2000 · AG